Health-Care System Is Fundamentally Broken: 23andMe CEO

The transcript discusses the challenges in the healthcare system, emphasizing the need for consumer-centric approaches. It highlights 23andMe's journey, including FDA regulations and the shift towards being a medical device company. The importance of understanding regulatory landscapes and engaging healthcare experts is stressed. The potential for consumer-driven transformation in healthcare, through collaboration and innovation, is explored. The transcript also covers the role of genetic data in personalized care and the necessity of partnerships with regulators to advance healthcare research and innovation.

What is one of the main issues with the current healthcare system according to the speaker?

• Limited access to doctors

• Consumer is not at the center

• Lack of technology

• High costs

Why did the FDA ask 23andMe to stop selling part of their product?

• It was too expensive

• It was not effective

• It was considered a medical device

• It was not popular

How did bringing in healthcare experts change 23andMe's business?

• Increased marketing budget

• Improved regulatory navigation

• Expanded product line

• Reduced costs

What transformation does the speaker want to see in healthcare?

• Fewer regulations

• Higher insurance premiums

• Consumer-driven system

• More government control

What role do consumers play in the speaker's vision for healthcare?

• Passive recipients

• Financial supporters

• Regulatory enforcers

• Active participants

How does 23andMe aim to transform research?

• By reducing costs

• By making it a real-time experience

• By limiting participation

• By focusing on pharmaceuticals

Why is it important for the speaker to engage with regulators in Washington, D.C.?

• To reduce taxes

• To understand motivations and players

• To expand internationally

• To increase sales